Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F2PZ
|
|||
| Former ID |
DIB014506
|
|||
| Drug Name |
SUN-E3001
|
|||
| Synonyms |
CHS-13340; PTH[1,34], Suntory; RhPTH(1-34); RhPTH[1,34], Daiichi Asubio Pharma; Recombinant human parathyroid hormone[residues 1-34] (osteoporosis), Asubio Pharma; RhPTH[1,34] (osteporosis), Asubio Pharma
Click to Show/Hide
|
|||
| Indication | Osteoporosis [ICD-11: FB83.0; ICD-10: M85.8] | Terminated | [1] | |
| Company |
Suntory Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Parathyroid hormone (PTH) | Target Info | Modulator | [2] |
| Reactome | Class B/2 (Secretin family receptors) | |||
| G alpha (s) signalling events | ||||
| WikiPathways | Endochondral Ossification | |||
| Osteoblast Signaling | ||||
| Vitamin D Receptor Pathway | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| Vitamin D Metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014905) | |||
| REF 2 | Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res. 2003 Mar;18(3):539-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.